OBJECTIVES: To determine the ability of lactoferrin in rheumatoid arthritis (RA) synovial fluid to bind "free" iron, and to study the regulatory mechanisms therein that control iron homeostasis. METHODS: "Free" iron was determined by the bleomycin assay and lactoferrin concentrations by enzyme linked immunosorbent assay. The activities of iron regulatory protein (IRP) and NF-kappa B in synovial fluid cells were assayed by mobility shift assay. RESULTS: 30% of synovial fluids contained "free" iron and in these, lactoferrin concentrations were significantly lower than in those with no "free" iron (p < 0.01). Addition of exogenous lactoferrin consistently reduced the amount of "free" iron in positive synovial fluids. IRP activity in synovial cells did not correlate with synovial fluid iron concentrations but did correlate with NF-kappa B activation and with serum C reactive protein. CONCLUSION: Lactoferrin may prevent iron mediated tissue damage in RA by reducing "free" synovial iron concentration when inflammatory stimuli have disregulated IRP mediated iron homeostasis.
OBJECTIVES: To determine the ability of lactoferrin in rheumatoid arthritis (RA) synovial fluid to bind "free" iron, and to study the regulatory mechanisms therein that control iron homeostasis. METHODS: "Free" iron was determined by the bleomycin assay and lactoferrin concentrations by enzyme linked immunosorbent assay. The activities of iron regulatory protein (IRP) and NF-kappa B in synovial fluid cells were assayed by mobility shift assay. RESULTS: 30% of synovial fluids contained "free" iron and in these, lactoferrin concentrations were significantly lower than in those with no "free" iron (p < 0.01). Addition of exogenous lactoferrin consistently reduced the amount of "free" iron in positive synovial fluids. IRP activity in synovial cells did not correlate with synovial fluid iron concentrations but did correlate with NF-kappa B activation and with serum C reactive protein. CONCLUSION: Lactoferrin may prevent iron mediated tissue damage in RA by reducing "free" synovial iron concentration when inflammatory stimuli have disregulated IRP mediated iron homeostasis.
Authors: D R Blake; P Winyard; J Lunec; A Williams; P A Good; S J Crewes; J M Gutteridge; D Rowley; B Halliwell; A Cornish Journal: Q J Med Date: 1985-07
Authors: Steffen Eipper; Robin Steiner; Adam Lesner; Marcin Sienczyk; David Palesch; Marc-Eric Halatsch; Ewa Zaczynska; Christopher Heim; Marcus D Hartmann; Michal Zimecki; Christian Rainer Wirtz; Timo Burster Journal: PLoS One Date: 2016-03-17 Impact factor: 3.240
Authors: Vishesh Kothary; Ryan S Doster; Lisa M Rogers; Leslie A Kirk; Kelli L Boyd; Joann Romano-Keeler; Kathryn P Haley; Shannon D Manning; David M Aronoff; Jennifer A Gaddy Journal: Front Cell Infect Microbiol Date: 2017-02-03 Impact factor: 5.293
Authors: S H Wong; N Francis; H Chahal; K Raza; M Salmon; D Scheel-Toellner; J M Lord Journal: Rheumatology (Oxford) Date: 2008-11-23 Impact factor: 7.580